Skip to main content

Published locations for Novel antifungal had favorable safety, efficacy profile for onychomycosis in phase IIB study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Novel antifungal had favorable safety, efficacy profile for onychomycosis in phase IIB study

User login

  • Reset your password
  • /content/novel-antifungal-had-favorable-safety-efficacy-profile-onychomycosis-phase-iib-study
  • /edermatologynews/article/134175/infectious-diseases/novel-antifungal-had-favorable-safety-efficacy
  • /familypracticenews/article/134175/infectious-diseases/novel-antifungal-had-favorable-safety-efficacy
  • /idpractitioner/article/134175/infectious-diseases/novel-antifungal-had-favorable-safety-efficacy
  • /internalmedicinenews/article/134175/infectious-diseases/novel-antifungal-had-favorable-safety
  • /infectiousdisease/article/134175/infectious-diseases/novel-antifungal-had-favorable-safety-efficacy
  • /internalmedicine/article/134175/infectious-diseases/novel-antifungal-had-favorable-safety-efficacy
  • /dermatology/article/134175/infectious-diseases/novel-antifungal-had-favorable-safety-efficacy
  • /familymedicine/article/134175/infectious-diseases/novel-antifungal-had-favorable-safety-efficacy